| Name: | CNS Therapeutics, Inc. |
| Jurisdiction: | Alaska |
| Legal type: | Business Corporation |
| Status: | Withdrawn |
| Date of registration: | 22 Oct 2010 (14 years ago) |
| Entity Number: | 125944 |
| Place of Formation: | DELAWARE |
| Mailing Address: | 332 MINNESOTA STREET, SUITE W1750, SAINT PAUL, MN 55101 |
| Name | Role | Shares |
|---|---|---|
| C T Corporation System | Registered Agent | - |
| Andrew D LaFrence | Previous Shareholder, Previous Vice President | 1.00 |
| John Foster (CEO) | Previous Shareholder, Previous President, Previous Director | 7.00 |
| John W Kapples | Vice President | - |
| Mark Trudeau | President | - |
| Matthew Nicolella | Assistant Secretary | - |
| Scott Bronson (CFO) | Previous Vice President, Previous Shareholder | 2.00 |
| Tom Prentice | Previous Secretary, Previous Vice President, Previous Shareholder | 1.00 |
Date of last update: 09 Feb 2025
Sources: State of Alaska - Department of Commerce, Community, and Economic Development
